Bio-Rad Laboratories Operating Income 2010-2024 | BIO
Bio-Rad Laboratories annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Bio-Rad Laboratories operating income for the quarter ending December 31, 2024 was $0.058B, a 38.81% decline year-over-year.
- Bio-Rad Laboratories operating income for the twelve months ending December 31, 2024 was $269M, a 20.37% decline year-over-year.
- Bio-Rad Laboratories annual operating income for 2024 was $0.269B, a 20.37% decline from 2023.
- Bio-Rad Laboratories annual operating income for 2023 was $0.338B, a 30% decline from 2022.
- Bio-Rad Laboratories annual operating income for 2022 was $0.483B, a 3.54% decline from 2021.
| Bio-Rad Laboratories Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $269 |
| 2023 | $338 |
| 2022 | $483 |
| 2021 | $500 |
| 2020 | $421 |
| 2019 | $230 |
| 2018 | $-103 |
| 2017 | $119 |
| 2016 | $56 |
| 2015 | $167 |
| 2014 | $150 |
| 2013 | $169 |
| 2012 | $264 |
| 2011 | $305 |
| 2010 | $284 |
| 2009 | $231 |
| Bio-Rad Laboratories Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $58 |
| 2024-09-30 | $64 |
| 2024-06-30 | $101 |
| 2024-03-31 | $45 |
| 2023-12-31 | $95 |
| 2023-09-30 | $91 |
| 2023-06-30 | $90 |
| 2023-03-31 | $62 |
| 2022-12-31 | $119 |
| 2022-09-30 | $95 |
| 2022-06-30 | $123 |
| 2022-03-31 | $146 |
| 2021-12-31 | $118 |
| 2021-09-30 | $157 |
| 2021-06-30 | $125 |
| 2021-03-31 | $101 |
| 2020-12-31 | $186 |
| 2020-09-30 | $110 |
| 2020-06-30 | $52 |
| 2020-03-31 | $74 |
| 2019-12-31 | $59 |
| 2019-09-30 | $57 |
| 2019-06-30 | $56 |
| 2019-03-31 | $57 |
| 2018-12-31 | $-227 |
| 2018-09-30 | $36 |
| 2018-06-30 | $44 |
| 2018-03-31 | $44 |
| 2017-12-31 | $56 |
| 2017-09-30 | $39 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $26 |
| 2016-12-31 | $-21 |
| 2016-09-30 | $28 |
| 2016-06-30 | $23 |
| 2016-03-31 | $26 |
| 2015-12-31 | $59 |
| 2015-09-30 | $33 |
| 2015-06-30 | $40 |
| 2015-03-31 | $34 |
| 2014-12-31 | $51 |
| 2014-09-30 | $33 |
| 2014-06-30 | $46 |
| 2014-03-31 | $20 |
| 2013-12-31 | $52 |
| 2013-09-30 | $29 |
| 2013-06-30 | $53 |
| 2013-03-31 | $35 |
| 2012-12-31 | $71 |
| 2012-09-30 | $66 |
| 2012-06-30 | $73 |
| 2012-03-31 | $54 |
| 2011-12-31 | $96 |
| 2011-09-30 | $74 |
| 2011-06-30 | $68 |
| 2011-03-31 | $67 |
| 2010-12-31 | $78 |
| 2010-09-30 | $75 |
| 2010-06-30 | $68 |
| 2010-03-31 | $63 |
| 2009-12-31 | $56 |
| 2009-09-30 | $67 |
| 2009-06-30 | $56 |
| 2009-03-31 | $51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.767B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.880B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.687B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.41 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.77 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |